| 1 |
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Robert John Motzer et al. · New England Journal of Medicine
Open access |
21 Mar 2018 |
4,756 |
| 2 |
Recovery of large carnivores in Europe’s modern human-dominated landscapes
Guillaume Chapron et al. · Science
Open access |
19 Dec 2014 |
1,906 |
| 3 |
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert John Motzer et al. · New England Journal of Medicine
Open access |
13 Feb 2021 |
1,811 |
| 4 |
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
A. Keith Stewart et al. · New England Journal of Medicine
Open access |
6 Dec 2014 |
1,342 |
| 5 |
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin et al. · Journal of Clinical Oncology
Open access |
23 Oct 2023 |
1,055 |
| 6 |
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
Brian I. Rini et al. · The Lancet
|
9 May 2019 |
1,029 |
| 7 |
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Meletios Athanasios Dimopoulos et al. · The Lancet Oncology
Open access |
5 Dec 2015 |
861 |
| 8 |
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Robert John Motzer et al. · The Lancet Oncology
Open access |
16 Aug 2019 |
797 |
| 9 |
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Toni K. Choueiri et al. · New England Journal of Medicine
Open access |
18 Aug 2021 |
792 |
| 10 |
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
Gerhard Hindricks, Miloš Táborský, Michael Glikson et al. · The Lancet
|
Aug 2014 |
746 |
| 11 |
Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development
Wanyang Liu et al. · PLoS ONE
Open access |
20 Jul 2011 |
729 |
| 12 |
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation
Pavel P. Osmancik et al. · Journal of the American College of Cardiology
Open access |
Jun 2020 |
651 |
| 13 |
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Michel Attal et al. · The Lancet
130 authors |
14 Nov 2019 |
648 |
| 14 |
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
Gilles Salles, Johannes Duell, Eva M. González-Barca et al. · The Lancet Oncology
Open access |
5 Jun 2020 |
535 |
| 15 |
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study
Emmanuel Ekanem et al. · Nature Medicine
Open access139 authors |
Jul 2024 |
484 |
| 16 |
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
Martin Hoenigl et al. · The Lancet Infectious Diseases
Open access |
17 Feb 2021 |
466 |
| 17 |
Randomized phase III study 306
Gregory L. Krauss et al. · Neurology
125 authors |
19 Apr 2012 |
433 |
| 18 |
Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke
Pierre Amarenco et al. · New England Journal of Medicine
Open access |
16 May 2018 |
376 |
| 19 |
Osteolysis around total knee arthroplasty: A review of pathogenetic mechanisms
Jiří Gallo, Stuart Barry Goodman, Yrjö Tapio Konttinen et al. · Acta Biomaterialia
Open access |
10 May 2013 |
359 |
| 20 |
Antibacterial Surface Treatment for Orthopaedic Implants
Jiří Gallo, Martin Holinka, Calin Stefan Moucha · International Journal of Molecular Sciences
Open access |
11 Aug 2014 |
344 |
| 21 |
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
Michael J. Morris et al. · The Lancet
Open access |
Sep 2024 |
333 |
| 22 |
Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022
Marco Pennazio et al. · Endoscopy
Open access |
24 Nov 2022 |
328 |
| 23 |
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders
F. M. Ross et al. · Haematologica
Open access |
27 Feb 2012 |
327 |
| 24 |
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Livio Pagano et al. · Journal of Hematology & Oncology
Open access196 authors |
14 Oct 2021 |
321 |
| 25 |
Practice-Based Research in the Creative Arts: Foundations and Futures from the Front Line
Linda Candy, Ernest Edmonds · Leonardo
Open access |
20 Jun 2017 |
315 |
| 26 |
Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)
Jan Václavík, Richard Sedlák, Martin Plachý et al. · Hypertension
|
3 May 2011 |
307 |
| 27 |
Obstructive sleep apnea, depression and cognitive impairment
Jakub Vaněk, Ján Pavlov Praško, Samuel Genzor et al. · Sleep Medicine
|
23 Mar 2020 |
305 |
| 28 |
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation
Pavel P. Osmancik et al. · Journal of the American College of Cardiology
Open access |
5 Nov 2021 |
301 |
| 29 |
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
Richard Langford, Jan Mareš, Alena Novotná et al. · Journal of Neurology
|
21 Nov 2012 |
299 |
| 30 |
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
Richard A. Lafayette, Pietro A. Canetta, Brad H. Rovin et al. · Journal of the American Society of Nephrology
Open access |
7 Nov 2016 |
294 |
| 31 |
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
Alison Patricia Klein et al. · Nature Communications
Open access123 authors |
2 Feb 2018 |
285 |
| 32 |
Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis
Amit Kishore, Martin Petřek · Frontiers in Immunology
Open access |
13 Aug 2021 |
284 |
| 33 |
Phenotypes of organ involvement in sarcoidosis
Jonas C. Schupp et al. · European Respiratory Journal
Open access |
2018 |
256 |
| 34 |
Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study
Bohuslav Melichar, Antoine Adenis, Albert Craig Lockhart et al. · The Lancet Oncology
|
26 Feb 2015 |
256 |
| 35 |
Periprosthetic Osteolysis: Mechanisms, Prevention and Treatment
Stuart Barry Goodman, Jiří Gallo · Journal of Clinical Medicine
Open access |
Dec 2019 |
247 |
| 36 |
Cardiac Rehabilitation Availability and Density around the Globe
Karam I. Turk-Adawi et al. · EClinicalMedicine
Open access |
3 Jul 2019 |
243 |
| 37 |
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial
Robert John Motzer et al. · Journal for ImmunoTherapy of Cancer
Open access |
Jul 2020 |
226 |
| 38 |
Recommendations regarding splenectomy in hereditary hemolytic anemias
Achille Iolascon et al. · Haematologica
Open access |
26 May 2017 |
225 |
| 39 |
The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association
Elena Arbelo et al. · European Heart Journal
Open access292 authors |
31 Jan 2014 |
212 |
| 40 |
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Jean‐Luc Vachiéry, Marion Delcroix, Hikmet Al‐Hiti et al. · European Respiratory Journal
Open access |
Feb 2018 |
209 |
| 41 |
Assistive products and the Sustainable Development Goals (SDGs)
Emma Tebbutt, Rebecca Brodmann, Johan Borg et al. · Globalization and Health
Open access |
29 Nov 2016 |
205 |
| 42 |
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
Jean Bousquet et al. · Allergy
Open access263 authors |
4 Jul 2015 |
205 |
| 43 |
Hypotension after induction of general anesthesia: occurrence, risk factors, and therapy. A prospective multicentre observational study
Ondřej Jor, Jan Máca, Jiřina Koutná et al. · Journal of Anesthesia
|
19 Jul 2018 |
199 |
| 44 |
Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension
Ján Rosa, Petr Widimský, Petr Toušek et al. · Hypertension
Open access |
25 Nov 2014 |
196 |
| 45 |
Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts
Rastislav Horos, Hanna IJspeert, Dagmar Pospı́šilová et al. · Blood
|
4 Nov 2011 |
195 |
| 46 |
Violent victimization of adult patients with severe mental illness: a systematic review
Klára Látalová, D. Kamarádová, Ján Pavlov Praško · Neuropsychiatric Disease and Treatment
ReviewOpen access |
Oct 2014 |
195 |
| 47 |
A review of national guidelines for management of COPD in Europe
Marc Miravitlles, Claus Franz Vogelmeier, Nicolás Roche et al. · European Respiratory Journal
Open access |
21 Jan 2016 |
193 |
| 48 |
Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function
Jaroslav Meluzı́n, Jiřı́ Mayer, Ladislav Groch et al. · American Heart Journal
|
26 Oct 2006 |
193 |
| 49 |
PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
Magdalena Čížková, Aurelie Susini, Sophie Vacher et al. · Breast Cancer Research
Open access |
13 Feb 2012 |
189 |
| 50 |
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
Barbora Knoppová, Colin Reily, Nicolas Maillard et al. · Frontiers in Immunology
Open access |
11 Apr 2016 |
187 |